Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C.
Hsu SJ, Yu ML, Su CW, Peng CY, Chien RN, Lin HH, Lo GH, Su WW, Kuo HT, Hsu CW, Yang SS, Yang SS, Tseng KC, Qin A, Huang YW, Chuang WL.
Hsu SJ, et al. Among authors: su ww, su cw.
J Formos Med Assoc. 2021 Mar;120(3):956-964. doi: 10.1016/j.jfma.2020.09.018. Epub 2020 Oct 16.
J Formos Med Assoc. 2021.
PMID: 33077341
Free article.
Clinical Trial.